Chronic HDV is considered the most severe form of viral hepatitis. ・Bulevirtide 2 mg is also approved for use in the European Economic Area (EEA). ・Gilead Sciences concluded the acquisition of Germany ...

Vir Biotechnology recently announced it will present data from its Phase 2 SOLSTICE trial of the tobevibart-elebsiran combination for chronic hepatitis delta at the EASL Congress 2026 in Barcelona, ...

Gilead Sciences received accelerated approval for a chronic hepatitis delta virus treatment from the Food and Drug Administration. The FDA said the Hepcludex treatment, known also as bulevirtide-gmod, ...

The Schwab U.S. Dividend Equity ETF (SCHD) and the iShares Core High Dividend ETF (HDV) are two of the best high-yield equity products out there.

Dividend growth and high yield equity strategies can produce very different results. VIG and HDV are some of the better ...

Not all high-yield ETFs are built the same. In the case of the two major high-dividend yield funds from iShares and Vanguard, ...

Tech stocks in a dividend ETF might sound tempting -- but think carefully about your strategy and risk tolerance.

HDV charges a marginally higher expense ratio than SCHD but has outperformed over the past year. SCHD offers a higher dividend yield and greater diversification across its 101 holdings. Both funds ...